The Must-Know Finance Concepts for Life Sciences Valuations - Part 2

This is part 2 of the whitepaper where we go into more detail on the key finance concepts and most common methodologies used to evaluate life sciences assets.

In this whitepaper, you’ll learn:

  • Valuation methodology most used by big pharma
  • The 3 fundamental concepts in valuation
  • Cash flow examples for different situations
  • And more


By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our  Privacy Policy .


Company team

Jeff Karan

Co-Founder and Managing Partner of WaveEdge Capital

Jeff brings over 30 years of investment banking and corporate advisory experience to WaveEdge Capital. In addition to his extensive knowledge of capital raising and merger & acquisitions, Jeff has advised clients on corporate strategy, business valuation, and a wide range of strategic partnership structures. Learn More

Company team

John Selig

Co-Founder and Managing Partner of WaveEdge Capital

John advises life sciences companies on M&A, licensing and financial strategy. He teaches the valuation and finance module at BIO’s Executive Management course for BD professionals and at Stanford Medical School’s Entrepreneurship program. Learn More

Sponsored by